Sharps Technology Inc. STSS
We take great care to ensure that the data presented and summarized in this overview for Sharps Technology Inc. is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Latest Institutional Activity in STSS
Top Purchases
Top Sells
About STSS
Sharps Technology Inc., a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. The company was incorporated in 2017 and is based in Melville, New York.
Insider Transactions at STSS
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 27
2025
|
Timothy James Ruemler Director |
SELL
Open market or private sale
|
Direct |
20,000
-15.75%
|
$320,000
$16.74 P/Share
|
|
Aug 25
2025
|
Timothy James Ruemler Director |
SELL
Open market or private purchase
|
Direct |
40,000
-16.44%
|
$400,000
$10.89 P/Share
|
|
Aug 22
2025
|
Paul K Danner Director |
BUY
Open market or private purchase
|
Direct |
400,000
+50.0%
|
$2,400,000
$6.41 P/Share
|
|
Aug 22
2025
|
Brenda Baird Simpson Director |
BUY
Open market or private purchase
|
Direct |
20,000
+50.0%
|
$120,000
$6.41 P/Share
|
|
Aug 22
2025
|
Soren Bo Christiansen Director |
BUY
Open market or private purchase
|
Direct |
80,000
+50.0%
|
$480,000
$6.41 P/Share
|
|
Aug 22
2025
|
Robert Michael Hayes Director |
BUY
Open market or private purchase
|
Direct |
100,000
+50.0%
|
$600,000
$6.41 P/Share
|
|
Aug 22
2025
|
Andrew R. Crescenzo Chief Financial Officer |
BUY
Open market or private purchase
|
Direct |
40,000
+50.0%
|
$240,000
$6.41 P/Share
|
|
Aug 22
2025
|
Jason L. Monroe Director |
BUY
Open market or private purchase
|
Direct |
80,000
+50.0%
|
$480,000
$6.41 P/Share
|
|
Jul 15
2025
|
Paul K Danner Director |
BUY
Open market or private purchase
|
Direct |
5
+50.0%
|
$100
$20.0 P/Share
|
|
Mar 31
2025
|
Robert Michael Hayes Director |
BUY
Open market or private purchase
|
Direct |
125,000
+23.77%
|
$0
$0.03 P/Share
|
|
Feb 28
2025
|
Robert Michael Hayes Director |
BUY
Open market or private purchase
|
Direct |
175,000
+38.81%
|
$0
$0.04 P/Share
|
|
Dec 05
2024
|
Robert Michael Hayes Director |
BUY
Open market or private purchase
|
Direct |
1,700
+0.56%
|
$3,400
$2.08 P/Share
|
|
Dec 04
2024
|
Robert Michael Hayes Director |
BUY
Open market or private purchase
|
Direct |
3,300
+0.42%
|
$3,300
$1.98 P/Share
|
|
Feb 20
2024
|
Robert Michael Hayes Director |
BUY
Open market or private purchase
|
Direct |
10,000
+9.44%
|
$0
$0.34 P/Share
|
|
Feb 06
2024
|
Robert Michael Hayes Director |
BUY
Open market or private purchase
|
Direct |
10,000
+10.43%
|
$0
$0.29 P/Share
|
|
Feb 02
2024
|
Robert Michael Hayes Director |
BUY
Open market or private purchase
|
Direct |
8,000
+9.54%
|
$0
$0.35 P/Share
|
|
Jan 31
2024
|
Robert Michael Hayes Director |
BUY
Open market or private purchase
|
Direct |
2,200
+1.61%
|
$0
$0.39 P/Share
|
|
Jan 03
2024
|
Timothy James Ruemler Director |
BUY
Open market or private purchase
|
Direct |
5,000
+0.47%
|
$0
$0.4 P/Share
|
|
Jan 02
2024
|
Timothy James Ruemler Director |
BUY
Open market or private purchase
|
Direct |
4,466
+0.42%
|
$0
$0.4 P/Share
|
|
Dec 22
2023
|
Timothy James Ruemler Director |
BUY
Open market or private purchase
|
Direct |
10,000
+0.94%
|
$0
$0.4 P/Share
|
Last 12 Months Summary
| Open market or private purchase | 1.03M shares |
|---|
| Open market or private purchase | 40K shares |
|---|---|
| Open market or private sale | 20K shares |